Optimization of transplantation of cell suspension in the treatment of vitiligo
Phase 2
Recruiting
- Conditions
- Vitiligo.disorders of pigmentation
- Registration Number
- IRCT20200127046282N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Having no treatment within past 6 months, No pregnancy or breast-feeding, Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment, No infection at recipient site, No history of keloid and or koebner phenomenon, No history of active hepatitis the B, C, or AIDS, No active uncontrolled chronic systemic disease
Exclusion Criteria
Vitiligo patients with active or progressive disease within last 12 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Repigmentation rate. Timepoint: Before, 1, 3 and 6 months after treatment. Method of measurement: The amount of melanin in the treated areas compared to before treatment using a maxameter device.
- Secondary Outcome Measures
Name Time Method